CAS 1041852-85-0

Fórmula: C23H27FN6O3

InChI: InChI=1S/C23H27FN6O3/c1-14-3-4-17(16(24)11-14)26-21-15-12-19(30-7-5-29(6-8-30)9-10-31)20(33-2)13-18(15)27-28-22(21)23(25)32/h3-4,11-13,31H,5-10H2,1-2H3,(H2,25,32)(H,26,27)

Chave InChI: CPDGCAFPSYOTGO-UHFFFAOYSA-N

SMILES: CC1=CC(=C(C=C1)NC2=C(N=NC3=CC(=C(C=C32)N4CCN(CC4)CCO)OC)C(=O)N)F

AZD7507

CAS: 1041852-85-0

AZD7507

Fórmula: C₂₃H₂₇FN₆O₃

Pureza: ≥98%

Peso molecular: 454.5

Ref: 54-BUP12697

4-((2-Fluoro-4-methylphenyl)amino)-6-(4-(2-hydroxyethyl)piperazin-1-yl)-7-methoxycinnoline-3-carboxamide

CAS: 1041852-85-0

Fórmula: C₂₃H₂₇FN₆O₃

Pureza: 95%

Cor e Forma: Solid

Peso molecular: 454.4973

Ref: IN-DA01EO16

AZD7507

CAS: 1041852-85-0

AZD7507 is a CSF-1R inhibitor with an IC50 of 32 nM. AZD7507 has antitumor activity.

Fórmula: C₂₃H₂₇FN₆O₃

Pureza: 99.55% - 99.78%

Cor e Forma: Solid

Peso molecular: 454.4973

Ref: TM-T14380

AZD7507

CAS: 1041852-85-0

AZD7507 is a small molecule that has been shown to have potential for the treatment of pancreatic cancer. It inhibits choline kinase, which is an enzyme that regulates the metabolism of phospholipids and fatty acids. AZD7507 was also shown to inhibit c-Src and c-Fms, two proteins that are involved in the regulation of chemokine production. This drug is not active against cells that are resistant to death receptors such as TRAIL or TNFα. AZD7507 has also been shown to be effective against cancer cells in culture, while showing little toxicity to normal cells.

Fórmula: C₂₃H₂₇FN₆O₃

Pureza: Min. 95%

Peso molecular: 454.5 g/mol

Ref: 3D-RRB85285